StartupsFinSMEsabout 2 hours ago
Epicrispr Biotechnologies Raises $90M Series C
1 min read
Epicrispr Biotechnologies raised $90 million in Series C funding. The financing will support the company's work in gene editing. The round marks a significant capital infusion for the biotech firm.
Level
Hype check
Tap to vote and see what everyone thinks.
